Atlas Trials

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Clinical trial NCT03878706 · RECRUITING

Trial details

NCT number
NCT03878706
Sponsor
University of Athens
Status
RECRUITING
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2017-11-03
Primary completion
2026-12-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.